TEAM PUBLICATIONS PROJECTS CONTACT LAB
2026
1. Olejarz W, Augustynowicz-Kopeć E, Głogowska A, Napiórkowska M, Szostek T, Filipek A, Szulczyk D. In vitro anticancer studies of new derivatives based on the furanocoumarin scaffold. Scientific Reports (2026) 16(1), 1412.
2. Szostek T, Szulczyk D. From obstacle to design advantage: activity cliff aware modeling for small-molecule drug discovery. Drug Discovery Today (2026) 31(1), 104589.
3. Szymańska-Majchrzak J, Głogowska A, Augustynowicz-Kopeć E, Greber KE, Ciura K, Olejarz W, Szostek T, Struga M, Szulczyk D. Discovery of a tetrazole-thiourea derivative as a potential agent against multidrug-resistant Staphylococcus aureus and Mycobacterium tuberculosis. Pharmacological Reports (2026)
2025
1. Olejarz W, Sadowski K, Roszkowski P, Bielenica A, Wiśniewski M, Struga M, Szulczyk D. Design and in vitro evaluation of novel tetrazole derivatives of dianisidine as anticancer agents targeting Bcl-2 apoptosis regulator. Scientific Reports (2025) 15(1), 17634.
2. Kunicki P, Grymm M, Pawiński T, Szulczyk D, Waligóra M, Kopeć G. A simple HPLC-UV method for monitoring therapeutic adherence in pulmonary arterial hypertension. Journal of Chromatography B (2025) 1252:1-10.
3. Szostek T, Otto-Ślusarczyk D, Dobrowolski MA, Wiśniewski M, Roszkowski P, Szulczyk D. Synthesis, cytotoxicity evaluation, and molecular dynamics of 4-thiazolidinone derivatives: A Potential Path to EGFR-Targeted Anticancer Therapy. Current Medicinal Chemistry (2025)
4. Pałka K, Podsadni K, Szymańska-Majchrzak J, Winnicka E. Deuterium isotope effects in mechanistic studies of biotransformations of l-Tyrosine and p-hydroxyphenylpyruvic acid catalyzed by the enzyme l-phenylalanine dehydrogenase. Nukleonika (2025) 70(2), 51-56.
2024
1. Woziński M, Greber K, Pastewska M, (...), Szulczyk D, (...), Ciura K. Modification of gradient HPLC method for determination of small molecules' affinity to human serum albumin under column safety conditions: Robustness and chemometrics study. Journal of Pharmaceutical and Biomedical Analysis. 2024;239:1-8.
2. Olejarz W, Sadowski K, Szulczyk D, Basak G. Advancements in Personalized CAR-T Therapy: Comprehensive Overview of Biomarkers and Therapeutic Targets in Hematological Malignancies. International Journal of Molecular Sciences. 2024;25(14):1-23.
3. Szostek T, Otto-Ślusarczyk D, Roszkowski P, Struga M, Szulczyk D. Exploring the bioactive potential of (2-imino-4-oxo-1,3-thiazolidin-5-yl)acetic acid derivatives: A comprehensive review. Results in Chemistry. 2024;11:1-11.
2023
1. Szulczyk D, Woziński M, Koliński M, (...), Struga M, Ciura K. Menthol- and thymol-based ciprofloxacin derivatives against Mycobacterium tuberculosis: in vitro activity, lipophilicity, and computational studies. Scientific Reports. 2023;13(1):1-14.
2022
1. Kalinowska D, Klepka M, Szulczyk D, Mielczarek-Puta M, Struga M. Complexes of 1,5-Disubstituted Tetrazole Derivatives with Cu(Ii) Ions: The Molecular Structure Determination by Xas Spectroscopy with the Cytotoxic and Microbiological Activity Evaluation. SSRN. 2022:1-18.
2. Szostek T, Szulczyk D, Szymańska-Majchrzak J, (...), Otto-Ślusarczyk D, Zawodnik A, (...), Struga M, Roszkowski P. Design and Synthesis of Menthol and Thymol Derived Ciprofloxacin: Influence of Structural Modifications on the Antibacterial Activity and Anticancer Properties. International Journal of Molecular Sciences. 2022;23(12):1-19.
3. Roszkowski P, Szymańska-Majchrzak J, Koliński M, Kmiecik S, Wrzosek M, Struga M, Szulczyk D. Novel Tetrazole-Based Antimicrobial Agents Targeting Clinical Bacteria Strains: Exploring the Inhibition of Staphylococcus aureus DNA Topoisomerase IV and Gyrase. International Journal of Molecular Sciences. 2022;23(1):1-14.